Epzicom (abacavir + lamivudine) - HIV Drug Information

Kushandisa Zvinodhaka, Kufungisisa, uye Zvinopesana

Epzicom inonzi yakagadzikana inoshandiswa inoshandiswa mukurapa HIV, iyo ine maviri antiretroviral agents , abacavir (Ziagen) pamwe lamivudine (Epivir). Zvose izvi zvinodhaka zvinoratidzirwa se nucleoside reverse transcriptase inhibitors (NRTIs) uye zvinoshanda nekuvhara enzyme inoda kupedzisa kushandiswa kwechirwere cheDNA mune imwe sero inotapukirwa.

Nokuita kudaro, HIV haina kukwanisa kudzokorora uye kupararira kune mamwe masero.

Epzicom yakagamuchirwa kuti ishandiswe kune vanhu vakuru neU.S. Food and Drug Administration (FDA) musi waAugust 2, 2004. Kunze kweU.S., mishonga inotengeswa pasi pezita rekutengesa Kivexa .

Kugadzirwa Kwezvinodhaka

Epzicom inowanikwa mufomu yebhetheni ine 600mg yeabacavir uye 300mg ye lamivudine. Mahwendefa akafukidzirwa mafirimu aya akareba mumashonga, machena, uye ane "GS FC2" kune rumwe rutivi.

Dosages

Rimwe piritsi rimwe nerimwe rinotorwa nemuromo kana kuti pasina zvokudya. Epzicom haisati yatorwa payo uye inofanira kushandiswa mukurapa pamwe chete pamwe chete kana mamwe madhiragi anonzi antiretroviral.

Nharaunda Dzakabatana

Maitiro akawandisa anowanzobatanidzwa ne Epzicom kushandiswa (kunoitika mumapurisa kusvika 9%) anosanganisira:

Zvizhinji zvezviratidzo izvi zvinowanzoguma kwenguva refu kunyange zvazvo vanhu vane zviratidzo zvemishonga inokonzerwa nemishonga inofanirwa kutsvaga kurapwa.

Mishonga yekushandisa zvinodhaka

Drug hypersensitivity dzimwe nguva inoratidzwa nevarwere vanobudiswa kune abacavir-ine mishonga yemishonga uye vanogona kuuraya kana vakasara vasina kutenderwa. Inoratidzirwa neviri kana kupfuura yezvikamu zvishanu zvinotevera:

Zviratidzo zve hypersensitivity zvinowanzoonekwa mukati memavhiki matanhatu ekutanga ekudzivirirwa, kunyange zvazvo zvingatowoneka pane imwe nhanho yekushandisa zvinodhaka. Kazhinji kutaura, zvisinei, zviitiko zvakawanda zvehutachiona hunoitika mukati memazuva gumi ekutanga kana zvakadaro.

Kana kugadziriswa kunofungidzirwa, Epzicom inofanira kumira pakarepo . Varwere vanofanira kuonana zvakare nachiremba wavo uye / kana kuenda kumakiriniki avo ari pedyo kana makamuri ekukurumidzira pasina kunonoka.

Vasati vatanga kurapwa naVaabacavir, vanachiremba vanokurudzirwa kuti vadzivirire HLA-B * 5701 zvakakwana sezvo varwere vane ruzivo rwezvekuberekwa kwechirwere vanozivikanwa sehuwandu hukuru hwebacavir hypersensitivity.

Zvidzidzo zvekuchipatara zvakaratidza kuti vanenge 8% vevarwere pavacavir vachawana hypersensitive reaction, dzimwe nguva yakakomba.

Contraindications

Kubatana Kwemishonga

Inorayirwa kuti varwere vanodha doro kushandiswa paEpzicom, apo varwere pa methadone vanofanira kurayira chiremba wavo kana Epzicom inorayirwa.

Kurapa Kufungidzirwa

Varwere vane renal (kidyo) kuora mwoyo hakufaniri kupiwa tsamba ye Epzicom kana kubvumirwa kwechiredinine iri pasi pe 50mL / miniti. Mune varwere vane njodzi yekudzivisa kusagadzikana, inosanganisira kuenzaniswa kwechiremera chekusika, serum phosphorus, urini glucose uye urine protein paunenge uchiita maitiro ekuongorora maitiro .

Kunyange zvazvo dzimwe dzidzo dzezvipfuwo dzakaratidza dambudziko rakawanda rekuberekwa kwekuberekwa mumakonzo nemaruva akazarurirwa kuabacavir kana lamivudine, hapana kusiyana kwakadaro kwakataurwa mumadzimai ane pamuviri anonyoreswa kumishonga pamwe nevaya vari vanhu vakawanda.

Munyika yakabudirira, zvinokurudzirwa kuti vanaamai vane HIV vadzivise kunyamwa nekuda kwekuwedzera kungozi yekuendesa HIV kune vacheche.

Sources:

US Food and Drug Administration (FDA). "FDA Inobvumira Zvimwe Zvinokonzerwa-Dose Mikana Drug Products For Treatment of HIV-1 Infection." Silver Spring, Maryland; yakabudiswa musi waAugust 2, 2004.